Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02705586 · ClinicalTrials.gov registry record · NA

Video Based Mindfulness Based Stress Reduction

A NA study of Parkinson's Disease, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
13
Enrollment target
2
Study locations

NCT02705586: Completed NA study of Parkinson's Disease, sponsored by Oregon Health and Science University.

NCT02705586 is a NA study of Parkinson's Disease that has completed, run by Oregon Health and Science University. The registered enrollment target is 13 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02705586, a NA study of Parkinson's Disease, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
2
Study locations

Study Summary

To evaluate the feasibility of a video based mindfulness intervention for stress reduction and to evaluate the cortisol response in persons with PD and their caregivers. The data from this project will be used for a future grant application of a stress reduction intervention in persons with PD.

Primary Outcome

Enzyme-linked immunoassay salivary cortisol levels (ng/mL) taken prior to Mindfulness-Based Stress Reduction will be compared to samples taken after the intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Mindfulness

Study Locations (2)

Oregon

  • Oregon Health & Science University - Portland
  • VA Portland Health Care System - Portland

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2016-03
Est. Completion 2016-07
Phase NA

What the finished NCT02705586 record still lists

NCT02705586 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness is the first listed.

NCT02705586 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT02705586 about?

NCT02705586 is a clinical study titled "Video Based Mindfulness Based Stress Reduction". To evaluate the feasibility of a video based mindfulness intervention for stress reduction and to evaluate the cortisol response in persons with PD and their caregivers. The data from this project will be used for a future grant application of a stress reduction intervention in persons with PD.

What is the current status of trial NCT02705586?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2016-03. Estimated completion is 2016-07.

What conditions does trial NCT02705586 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT02705586?

The interventions under investigation include: Mindfulness (BEHAVIORAL).

Who is sponsoring clinical trial NCT02705586?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02705586 being conducted?

This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02705586's enrollment target sits among peer trials

13 139th of 158 higher than 17 of 158 other Parkinson's Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02705586, the US trial registry maintained by the National Library of Medicine. NCT02705586 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.